The Official Journal of EuroPCR and the European Association of Percutaneous Coronary Interventions (EAPCI)

Marie-Claude Morice

Showing 1-20 of 63 articles
Geographical variations in left main coronary artery revascularisation: a pre-specified analysis of the EXCEL trial
Myat A, Hildick-Smith D, de Belder A, Trivedi U, Crowley A, Morice M, Kandzari D, Lembo N, Brown W, Serruys P, Kappetein A, Sabik J, Stone G
July 2, 2021 | 10.4244/EIJ-D-21-00338
Drug-coated stents versus bare metal stents in Academic Research Consortium-defined high bleeding risk patients
Marquis-Gravel G, Urban P, Copt S, Capodanno D, Pocock S, Sadozai Slama S, Stoll H, Tanguay J, Mehran R, Leon M, Rao S, Morice M, Krucoff M
June 25, 2021 | 10.4244/EIJ-D-20-00749
Impact of the CABG SYNTAX score on all-cause death at 10 years: a SYNTAX Extended Survival (SYNTAXES) substudy
Takahashi K, Thuijs D, Hara H, Wang R, Mohr F, Morice M, Holmes D, Kappetein A, Head S, Onuma Y, Serruys P
May 16, 2021 | 10.4244/EIJ-D-20-00170
Procedural characteristics and clinical outcomes in patients undergoing percutaneous coronary intervention for left main trifurcation disease: the EXCEL trial
Kandzari D, Gershlick A, Serruys P, Leon M, Morice M, Simonton C, Lembo N, Mansour S, Sabaté M, Sabik J, Kappetein A, Dressler O, Stone G
December 18, 2020 | 10.4244/EIJ-D-19-00686
Bioresorbable vascular scaffold versus metallic drug-eluting stent in patients at high risk of restenosis: the COMPARE-ABSORB randomised clinical trial
Smits P, Chang C, Chevalier B, West N, Gori T, Barbato E, Tarantini G, Kocka V, Achenbach S, Dudek D, Escaned J, Wlodarczak A, Abdel-Wahab M, Esposito G, Tijssen J, Morice M, Onuma Y, van Geuns R
October 23, 2020 | 10.4244/EIJ-D-19-01079
Influence of final kissing balloon inflation on long-term outcomes after PCI of distal left main bifurcation lesions in the EXCEL trial
Kini A, Dangas G, Baber U, Vengrenyuk Y, Kandzari D, Leon M, Morice M, Serruys P, Kappetein A, Sabik J, Dressler O, Mehran R, Sharma S, Stone G
June 25, 2020 | 10.4244/EIJ-D-19-00851
Why stronger radiation safety measures are essential for the modern workforce. A perspective from EAPCI Women and Women as One
Buchanan G, Ortega R, Chieffo A, Mehran R, Gilard M, Morice M
May 20, 2020 | 10.4244/EIJV16I1A5
Does an occluded RCA affect prognosis in patients undergoing PCI or CABG for left main coronary artery disease? Analysis from the EXCEL trial
Chen S, Karmpaliotis D, Redfors B, Shlofmitz E, Ben-Yehuda O, Crowley A, Mehdipoor G, Puskas J, Kandzari D, Banning A, Morice M, Taggart D, Sabik J, Serruys P, Kappetein A, Stone G
August 9, 2019 | 10.4244/EIJ-D-19-00263
Percutaneous coronary and structural interventions in women: a position statement from the EAPCI Women Committee
Chieffo A, Buchanan G, Mehilli J, Capodanno D, Kunadian V, Petronio A, Mikhail G, Capranzano P, Gonzalo N, Karam N, Manzo-Silberman S, Schüpke S, Byrne R, Capretti G, Appelman Y, Morice M, Presbitero P, Radu M, Mauri Ferre J
December 7, 2018 | 10.4244/EIJ-D-18-00225
Coronary interventions
Radial versus femoral artery access in patients undergoing PCI for left main coronary artery disease: analysis from the EXCEL trial
Chen S, Redfors B, Liu Y, Ben-Yehuda O, Morice M, Leon M, Kandzari D, Mehran R, Lembo N, Banning A, Merkely B, Kappetein A, Sabik J, Serruys P, Stone G
November 20, 2018 | 10.4244/EIJ-D-18-00711
Biolimus A9 polymer-free coated stents in high bleeding risk patients undergoing complex PCI: evidence from the LEADERS FREE randomised clinical trial
Lipiecki J, Brunel P, Morice M, Roguelov C, Walsh S, Richardt G, Eerdmans P, Zambahari R, Berland J, Copt S, Stoll H, Urban P
July 20, 2018 | 10.4244/EIJ-D-18-00293
Culotte stenting for coronary bifurcation lesions with 2nd and 3rd generation everolimus-eluting stents: the CELTIC Bifurcation Study
Walsh S, Hanratty C, Watkins S, Oldroyd K, Mulvihill N, Hensey M, Chase A, Smith D, Cruden N, Spratt J, Mylotte D, Johnson T, Hill J, Hussein H, Bogaerts K, Morice M, Foley DP
June 14, 2018 | 10.4244/EIJ-D-18-00346
Stable CAD
The impact of chronic kidney disease on outcomes following percutaneous coronary intervention versus coronary artery bypass grafting in patients with complex coronary artery disease: five-year follow-up of the SYNTAX trial
Milojevic M, Head S, Mack M, Mohr F, Morice M, Dawkins K, Holmes D, Serruys P, Kappetein A
May 20, 2018 | 10.4244/EIJ-D-17-00620
Two-year outcomes of high bleeding risk patients with acute coronary syndrome after Biolimus A9 polymer-free drug-coated stents: a LEADERS FREE substudy
Jensen C, Naber C, Urban P, Ong PJ, Valdés Chávarri M, Abizaid A, Pocock S, Fabbiocchi F, Dubois C, Copt S, Stoll H, Morice M
March 20, 2018 | 10.4244/EIJ-D-17-00720
Polymer-free drug-coated coronary stents are cost-effective in patients at high bleeding risk: economic evaluation of the LEADERS FREE trial
Filipovic-Pierucci A, Durand-Zaleski I, Butel T, Greene S, Hovasse T, Iñiguez A, Nazzaro M, Oldroyd K, Talwar S, Richardt G, Windhovel U, Urban P, Morice M
February 20, 2018 | 10.4244/EIJ-D-17-00286
Coronary interventions
Does geographical variability influence five-year MACCE rates in the multicentre SYNTAX revascularisation trial?
Roy A, Chevalier B, Lefèvre T, Louvard Y, Segurado R, Sawaya F, Spaziano M, Neylon A, Serruys P, Dawkins K, Kappetein A, Mohr F, Colombo A, Feldman T, Morice M
September 20, 2017 | 10.4244/EIJ-D-16-00991
Coronary interventions
Chronic total coronary occlusion treated by percutaneous coronary intervention: long-term outcome in patients with and without diabetes
Sanguineti F, Garot P, O’Connor S, Watanabe Y, Spaziano M, Lefèvre T, Hovasse T, Benamer H, Unterseeh T, Chevalier B, Morice M, Louvard Y
February 3, 2017 | 10.4244/EIJ-D-15-00278
Coronary interventions
The SYNERGY II Everolimus elutiNg stent In patients Older than 75 years undergoing coronary Revascularisation associated with a short dual antiplatelet therapy (SENIOR) trial: rationale and design of a large-scale randomised multicentre study
Varenne O, Cuisset T, Chaib A, Morice M, Sabaté M, Koh T-H, Durand-Zaleski I, Hanon O, Bogaerts K, Sinnaeve P
January 20, 2017 | 10.4244/EIJY15M12_02
Coronary interventions
Design and rationale for a randomised comparison of everolimus-eluting stents and coronary artery bypass graft surgery in selected patients with left main coronary artery disease: the EXCEL trial
Kappetein A, Serruys P, Sabik J, Leon M, Taggart D, Morice M, Gersh B, Pocock S, Cohen D, Wallentin L, Ben-Yehuda O, Van Es G-A, Simonton C, Stone G
September 18, 2016 | 10.4244/EIJV12I7A141
Coronary interventions
Long-term clinical outcomes after percutaneous coronary intervention versus coronary artery bypass grafting for acute coronary syndrome from the DELTA registry: a multicentre registry evaluating percutaneous coronary intervention versus coronary artery bypass grafting for left main treatment
Pyxaras S, Hunziker L, Chieffo A, Meliga E, Latib A, Park S, Onuma Y, Capranzano P, Valgimigli M, Narbute I, Makkar R, Palacios I, Kim Y, Buszman P, Chakravarty T, Sheiban I, Mehran R, Margey R, Agnihotri A, Marra S, Capodanno D, Leon M, Moses J, Fajadet J, Lefèvre T, Morice M, Erglis A, Tamburino C, Alfieri O, Serruys P, Colombo A, Naber C
August 5, 2016 | 10.4244/EIJV12I5A102

Latest news

NEW ISSUE
EAPCI/ACVC consensus on pVADs, coronary physiology mini focus, a new analysis from the COAPT trial, patient selection for tricuspid interventions and more…
July 20, 2021
Ahead of print
Joint EAPCI/ACVC expert consensus document on pVADs
July 20, 2021
Editorial
Beyond ischaemia: is there a place for physiologic and anatomic evaluations of coronary lesions?
Gilles Montalescot
July 20, 2021
JAA
This Week's JAA's: Principles and Pitfalls in CFT, Brachial access for PCI....
July 20, 2021
Editorial
Coronary flow capacity: where to next?
Nils P. Johnson
July 20, 2021
NEW
EuroIntervention's new impact factor!
July 1, 2021
STATE OF THE ART
Completeness of Revascularisation in ACS Patients with Multivessel Disease
Valeria Paradies et al.
June 25, 2021
Coronary
Valvular disease
Heart failure
Peripheral
Hypertension
Stroke